A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression
about
Colony-stimulating factors for chemotherapy-induced febrile neutropeniaGranulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphomaColony-stimulating factors for prevention of myelosuppressive therapy-induced febrile neutropenia in children with acute lymphoblastic leukaemiaMaltose-binding protein fusion allows for high level bacterial expression and purification of bioactive mammalian cytokine derivativesKeeping cancer guidelines current: results of a comprehensive prospective literature monitoring strategy for twenty clinical practice guidelines.Carboplatin-induced hematotoxicity among patients with non-small cell lung cancer: Analysis on clinical adverse events and drug-gene interactions.Comparison of G-CSF and GM-CSF adverse event profiles in office-based practices: preliminary study results.Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patientsNeutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin LymphomaColony stimulating factors for chemotherapy induced febrile neutropenia.Immunomodulatory Response Triggered by the Alkaloids, 3-Amino-7-Benzylbenzimidazo[3,2-a] Quinolinium Chloride (ABQ-48) and 3-Nitro-7-Benzylbenzimidazo [3,2-a] Quinolinium Chloride (NBQ-48)Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.Is There Additive Therapeutic Effect When GCSF Combined with Adipose-Derived Stem Cell in a Rat Model of Acute Spinal Cord Injury?GM-CSF as successful salvage therapy of metamizole (dipyrone)-induced agranulocytosis with Fournier's gangrene and severe septic shock in an adolescent.Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy-evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Onc
P2860
Q24193040-074EF217-B7C3-4FB5-A06E-F13C4A4CC6EEQ24240753-260F8182-84E0-4E7E-8A95-D5E4B9EB00A5Q24246566-98A4FDED-540C-4746-BD3E-55E9CA3524C5Q28542860-AE7153C0-B148-4EBA-944F-77CC75563A86Q33201948-CD22F536-7ED2-4ECF-B412-AADA23CD54D7Q33436456-3E71315F-43CB-4234-84B3-7623BA9C1202Q33975239-0C41D254-E509-47D8-B863-AB75AB68896DQ34344146-CC31CA2C-AD52-44EB-ACC0-54D856CAABF9Q35038832-9D28A762-4A7F-468E-BD2F-8B4A61F90435Q35199419-1258631C-1254-49B5-9762-B9C7852F406DQ35743952-0910D629-855E-4853-B381-48FE7E6AC2E0Q36103329-6A9247C9-46B5-48B1-874B-5B625976E448Q41257199-478224F8-D6FD-4EAF-AE70-F188CF072E82Q41877398-62F9054E-A9CE-4D0D-9CE0-2E730BAE231FQ42223844-C682C56C-5944-4D54-AD04-4CF77DEF0DF0
P2860
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression
description
1998 nî lūn-bûn
@nan
1998 թուականին հրատարակուած գիտական յօդուած
@hyw
1998 թվականին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A comparison of efficacy of sa ...... erapy-induced myelosuppression
@ast
A comparison of efficacy of sa ...... erapy-induced myelosuppression
@en
A comparison of efficacy of sa ...... erapy-induced myelosuppression
@nl
type
label
A comparison of efficacy of sa ...... erapy-induced myelosuppression
@ast
A comparison of efficacy of sa ...... erapy-induced myelosuppression
@en
A comparison of efficacy of sa ...... erapy-induced myelosuppression
@nl
prefLabel
A comparison of efficacy of sa ...... erapy-induced myelosuppression
@ast
A comparison of efficacy of sa ...... erapy-induced myelosuppression
@en
A comparison of efficacy of sa ...... erapy-induced myelosuppression
@nl
P2093
P2860
P3181
P1433
P1476
A comparison of efficacy of sa ...... erapy-induced myelosuppression
@en
P2093
G A Patton
H M Barnes
J A Miller
J A Shields
J Cantrell
J H Harvey
J M Feigert
P2860
P304
P3181
P356
10.3109/07357909809115775
P407
P577
1998-01-01T00:00:00Z